Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Antibody Drug Conjugates Industry By 2029?

The market size for antibody drug conjugates has seen remarkable growth in the past years. The market, which is set to rise from $13.57 billion in 2024 to $16.53 billion in 2025, will have a compound annual growth rate (CAGR) of 21.8%. The surge witnessed in the past can be credited to the increasing cases of cancer, successful clinical outcomes and approvals, strategic partnerships, increased R&D investment, and strategies centred around market expansion.

The market size for antibody drug conjugates is projected to experience substantial growth in the coming years, escalating to “$37.9 billion in 2029 with a compound annual growth rate (CAGR) of 23.1%. The expansion during the forecasted period can be credited to novel ADCS, broader indications, heightened emphasis on personalized medicine, escalating investments in precision treatment, and rising awareness of healthcare. Significant trends during the forecast period include progress in conjugation technologies, enhanced comprehension of tumor biology, technological progression, expanding therapeutic applications, and cutting-edge conjugation technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

What Market Forces Are Contributing To The Growth Of The Antibody Drug Conjugates Market?

The surge in global cancer incidences propels the antibody-drug conjugates market. Obesity, smoking, alcohol consumption, and unhealthy dietary practices are primarily accountable for most cancer types. Cancer Research UK anticipates 27.5 million fresh cancer instances each year by 2040. The escalating cancer occurrences are foreseen to amplify the need for antibody-drug conjugates, fuelling the expansion of the market.

What Segmentation Insights Are Provided In The Antibody Drug Conjugates Market Research?

The antibody drug conjugates market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Other Types

2) By Product: Adcertis, Kadcyla, Other Products

3) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology

4) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications

5) By End User: Hospital, Clinics, Other End Users

Subsegments:

1) By Monoclonal Antibodies: IgG-based Monoclonal Antibodies, IgM-based Monoclonal Antibodies, Bispecific Antibodies

2) By Linker: Cleavable Linkers, Non-cleavable Linkers, Stable Linkers

3) By Drug/Toxin: Cytotoxic Drugs, Chemotherapeutic Agents, Radioisotopes

4) By Other Types: Enzyme-Targeted ADCs, Antibody-Drug Conjugates with Immune Modulators

Which Notable Trends Are Transforming The Antibody Drug Conjugates Market Outlook?

The production of antibody-drug conjugates is overseen by various regulatory entities, including the Food and Drug Administration in the USA. Although there is no specific guidance for the industry regarding ADC development in the USA, the FDA uses the existing guidelines for small drugs and monoclonal antibodies as a framework for regulation. The Offices of Biotechnology Products (OBP) and Pharmaceutical Quality at the FDA, which are primarily focused on product quality, supervise the manufacture of the antibody component of the ADC and regulate the control strategies for both the antibody intermediate and the drug substance (DS) and drug product (DP). Overseeing the adequacy of the payload and linker, conjugation reactions, and control strategy components falls under the remit of the small molecule review groups, nested within the Office of Pharmaceutical Quality.

Which Firms Are Driving Innovation Within The Antibody Drug Conjugates Market?

Major companies operating in the antibody drug conjugates market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Millennium Pharmaceuticals Inc., Gilead Sciences Inc., Daiichi Sankyo Company Limited, Sorrento Therapeutics Inc., Astellas Pharma Inc., Zydus Lifesciences Limited, Seagen Inc., Seagen Inc., Synthon BV, Genentech Inc., ImmunoGen Inc., Nordic Nanovector ASA, ADC Therapeutics SA, Immunomedics Inc., Mersana Therapeutics Inc., Heidelberg Pharma AG, Celldex Therapeutics Inc., Oxford BioTherapeutics, Concortis Biotherapeutics Corp., Antikor BioPharma Ltd., Eisai Co. Ltd., Merck KGaA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Antibody Drug Conjugates Market?

North America was the largest region in the antibody-drug conjugates (ADCs) market in 2024. The Middle East is expected to be the fastest-growing region in the global antibody drug conjugates market share during the forecast period. The regions covered in the antibody drug conjugates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2569&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model